Research Article
Bilal J Kamal, Waleed M Ali
Abstract
Abstract Background: Metabolic syndrome (MetS) is a cluster of metabolic abnormalities that strongly associated with the development of cardiovascular disease (CVD) and type 2 diabetes mellitus T2DM. There are an increasing number of metabolic syndrome (MetS) patients worldwide, and there is no exception in Iraq. Regardless of which criteria are used for diagnosis of metabolic syndrome, the first concern is early detection of cardiovascular complication and early intervention. Aim: The purpose of this study is to assess the prevalence of clinical and biomarker component of metabolic syndrome using NCEP ATP III (2005), IDF (2006) among Iraqi sample of patients with type II diabetes. Patients and methods: Four hundred-six, type 2 diabetic patients attending Baba GurGur Diabetic Center in K1 Hospital/ Northern Oil Company –Kirkuk, from 1st April till 30th June, were subjected randomly to this descriptive cross-sectional study with mean age of 54.8740 ± 9.648. Clinical and biochemical data were collected and the data was analyzed in order to identify prevalence of MetS in these patients. Results: The result showed that there was statistically significant relation between sex and MetS in both Definitions [NCEP ATP 111and IDF] with p value (0.000). The overall prevalence of MetS among the studied sample was 51.2% and 48.9% in both definitions respectively. The frequency ofmetabolic Syndrome component was higher for Low HDL Cholesterol and there was a highly statistically significant relation between low HDL among female vs. male with p value (0.000). High frequencies of MetS were between the age group 50-59 years. Regarding BMI, diabetic patients with BMI (25-29.9) and (30-39.9) having highest frequency of Mets. Conclusion: The prevalence of MetS and its components using NCEP-ATPIII and IDF criteria amongst a sample of T2DM Iraqi patients was high. Early diagnosis and proper management is requested for metabolic syndrome to prevent cardiovascular complication.